Shearman And Sterling

Event Nov 28, 2018

Financing Options for Early and Mid-Stage Companies

  • New York, NY

Partners Mark Kessel (New York–Capital Markets) and Rob Masella (New York–Mergers & Acquisitions), Co-Heads of the Healthcare Industry Group, partner Bjorn Bjerke (New York–Finance) and Senior Director Vasilios Kofitsas (Back Bay Life Science Advisors) spoke on the “Financing Options for Early and Mid-Stage Companies” panel at the Nordic-American Life Science Conference hosted in our New York office.

Discussion topics included:

  • Forms of Risk-Sharing Development Financings
  • Comparison of Investment Focus
  • Relative Comparison of Clinical Development Financing Alternatives